106 related articles for article (PubMed ID: 18378030)
1. Attention changes in epilepsy patients following 3-month topiramate or valproate treatment revealed by event-related potential.
Sun W; Wang Y; Wang W; Wu X
Int J Psychophysiol; 2008 Jun; 68(3):235-41. PubMed ID: 18378030
[TBL] [Abstract][Full Text] [Related]
2. Antiepileptic drugs and the significance of event-related potentials.
Sun W; Wang W; Wu X; Wang Y
J Clin Neurophysiol; 2007 Jun; 24(3):271-6. PubMed ID: 17545831
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
[TBL] [Abstract][Full Text] [Related]
4. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?
Latour P; Biraben A; Polard E; Bentué-Ferrer D; Beauplet A; Tribut O; Allain H
Hum Psychopharmacol; 2004 Apr; 19(3):193-203. PubMed ID: 15079854
[TBL] [Abstract][Full Text] [Related]
5. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B;
Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy.
Fritz N; Glogau S; Hoffmann J; Rademacher M; Elger CE; Helmstaedter C
Epilepsy Behav; 2005 May; 6(3):373-81. PubMed ID: 15820346
[TBL] [Abstract][Full Text] [Related]
7. [Changes of the event related potential P300 following topiramate treatment in children with epilepsy].
Yang W; Li M
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):583-5. PubMed ID: 18947474
[TBL] [Abstract][Full Text] [Related]
8. Differential cognitive and behavioral effects of topiramate and valproate.
Meador KJ; Loring DW; Hulihan JF; Kamin M; Karim R;
Neurology; 2003 May; 60(9):1483-8. PubMed ID: 12743236
[TBL] [Abstract][Full Text] [Related]
9. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication.
Kockelmann E; Elger CE; Helmstaedter C
Epilepsy Behav; 2004 Oct; 5(5):716-21. PubMed ID: 15380124
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.
Aldenkamp AP; Baker G; Mulder OG; Chadwick D; Cooper P; Doelman J; Duncan R; Gassmann-Mayer C; de Haan GJ; Hughson C; Hulsman J; Overweg J; Pledger G; Rentmeester TW; Riaz H; Wroe S
Epilepsia; 2000 Sep; 41(9):1167-78. PubMed ID: 10999556
[TBL] [Abstract][Full Text] [Related]
11. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A
Seizure; 2018 May; 58():90-95. PubMed ID: 29679911
[TBL] [Abstract][Full Text] [Related]
12. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
Helmstaedter C; Witt JA
Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
[TBL] [Abstract][Full Text] [Related]
13. Cognitive effects of topiramate revealed by standardised low-resolution brain electromagnetic tomography (sLORETA) of event-related potentials.
Jung KY; Cho JW; Joo EY; Kim SH; Choi KM; Chin J; Park KW; Hong SB
Clin Neurophysiol; 2010 Sep; 121(9):1494-1501. PubMed ID: 20678718
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy.
Rosenfeld WE; Liao S; Kramer LD; Anderson G; Palmer M; Levy RH; Nayak RK
Epilepsia; 1997 Mar; 38(3):324-33. PubMed ID: 9070595
[TBL] [Abstract][Full Text] [Related]
15. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy.
Privitera MD; Brodie MJ; Mattson RH; Chadwick DW; Neto W; Wang S;
Acta Neurol Scand; 2003 Mar; 107(3):165-75. PubMed ID: 12614309
[TBL] [Abstract][Full Text] [Related]
16. Influence of lamotrigine and topiramate on MDR1 expression in difficult-to-treat temporal lobe epilepsy.
Wang-Tilz Y; Tilz C; Wang B; Tilz GP; Stefan H
Epilepsia; 2006 Feb; 47(2):233-9. PubMed ID: 16499746
[TBL] [Abstract][Full Text] [Related]
17. Topiramate pharmacokinetics in children with epilepsy aged from 6 months to 4 years.
Mikaeloff Y; Rey E; Soufflet C; d'Athis P; Echenne B; Vallée L; Bouhours P; Grinspan A; Dulac O; Pons G; Chiron C
Epilepsia; 2004 Nov; 45(11):1448-52. PubMed ID: 15509246
[TBL] [Abstract][Full Text] [Related]
18. The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate.
Gomer B; Wagner K; Frings L; Saar J; Carius A; Härle M; Steinhoff BJ; Schulze-Bonhage A
Epilepsy Behav; 2007 May; 10(3):486-94. PubMed ID: 17409025
[TBL] [Abstract][Full Text] [Related]
19. Topiramate increases the risk of valproic acid-induced encephalopathy.
Noh Y; Kim DW; Chu K; Lee ST; Jung KH; Moon HJ; Lee SK
Epilepsia; 2013 Jan; 54(1):e1-4. PubMed ID: 22691153
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate.
de Araujo Filho GM; Pascalicchio TF; Lin K; Sousa PS; Yacubian EM
Epilepsy Behav; 2006 May; 8(3):606-9. PubMed ID: 16504593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
